2009年4月28日 星期二

Swine Flu 2009 Outbreak -- Sequence information from CDC

This is the general structure of  an influenza A virion. You can reference the corresponding functions for the abbreviations (PB2, PB1, PA, HA, NP, NA, NS) used in following table from CDC.




 


The following swine influenza A (H1N1) sequences were submitted to NCBI and are available in GenBank:


April 27, 2009, submitted by CDC:






















































































 



PB2



PB1



PA



HA



NP



NA



MP



NS



Influenza A virus
(A/California/04/2009(H1N1))



FJ966079



FJ966080



FJ966081



FJ966082



FJ966083



FJ966084



FJ966085



FJ966086



Influenza A virus
(A/California/05/2009(H1N1))



FJ966955



FJ966958



FJ966957



FJ966952



FJ966953



FJ966956



FJ966954



 



Influenza A virus
(A/California/06/2009(H1N1))



FJ966963



FJ966965



FJ966964



FJ966960



FJ966961





FJ966962





Influenza A virus
(A/California/07/2009(H1N1))



FJ966976



FJ966978



FJ966977



FJ966974







FJ966975





Influenza A virus
(A/California/09/2009(H1N1))









FJ966971





FJ966973



FJ966972





Influenza A virus
(A/Texas/04/2009(H1N1))









FJ966982



FJ966979



FJ966981



FJ966983





Influenza A virus
(A/Texas/05/2009(H1N1))







FJ966970



FJ966959



FJ966967



FJ966969



FJ966968



FJ966966



You can find more information by clicking following website:


 


In fact, CDC has pointed this out in an article "Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008." published on Antimicribial Agents and Chemotherapy, September 2008, p. 3284-3292, Vol. 52, No. 9.


Following is a table for characterization of extreme and mild outliers among A(H1N1) viruses from past seasons in 2007:


TABLE 3. Characterization of extreme and mild outliers among A(H1N1) viruses from three previous seasonsa











































































































SeasonStrainMean IC50 ± SDc (nM)



Outlier(s)/drug(s)dNA mutation(s)eAccession no.
OseltamivirZanamivir



2005-2006A/Zhejiang/Xiangshan522/2006b131.85 ± 31.552.56 ± 0.01E/OH274YEU879082
2006-2007A/Georgia/20/2006b383.01 ± 143.69f2.55 ± 1.02E/OH274YEU516197i
2006-2007A/Massachusetts/5/2007b258.48 ± 41.56g1.71 ± 0.28E/OH274YEU516028
2006-2007A/Texas/31/2007b285.56 ± 18.051.14 ± 0.33E/OH274YEU516027
2006-2007A/Minnesota/23/2007b225.61 ± 13.850.99 ± 0.05E/OH274YEU516141
2006-2007A/Gansu/Chenguan/1129/2007b126.89 ± 1.960.49 ± 0.25E/OH274YEU879064
2005-2006A/Guangdongluohu/1232/20068.76 ± 4.682.33 ± 1.47M/OD79G, S247GEU879081
2006-2007A/Hubei/Jiangan/1251/20066.75 ± 5.2413.50 ± 12.24M/Z, M/OH126NEU879078
2006-2007A/Thailand/708/20064.51 ± 1.362.76 ± 0.01hM/ONoneEU879083
2005-2006A/Zhejiang/Xiaocheng/1345/20064.21 ± 0.680.54 ± 0.12M/OS247GEU879079
2005-2006A/Thailand/674/20061.95 ± 0.697.12 ± 3.64M/ZG248REU879080

a Includes viruses collected from 1 October 2004 to 30 September 2007.

b Resistant virus.

c Mean IC50 ± SD values were calculated from data collected from at least three independent experiments.

d E, extreme; M, mild; O, oseltamivir (IC50s > 2.89 nM); Z, zanamivir (IC50s > 3.89 nM).

e Boldface type indicates a mutation in the NA active site.

f A 638-fold increase in the IC50 for oseltamivir compared to that of the matching virus A/Georgia/17/2006 (accession no. EU100630).

g A 1,616-fold increase in IC50 for oseltamivir compared to that of the matching virus A/Massachusetts/6/2006 (accession no. EU100634).

h IC50s were below the cutoff after retesting.

i Additional sequences for this virus are those of accession no. EU516198 and EU516199.


 


H247Y is quite resistant to Roche's Tamiflu (oseltamivir phosphate). I am not very sure if the strain found in Mexico with the same mutation H247Y. However, the news from the World Health Organization seems good for us, and, of course, for Roche...........“The information we have to far is the strain is receptive to Tamiflu,” WHO spokesman Aphaluck Bhatiasevi told Dow Jones Newswires.


沒有留言:

張貼留言